Labcorp Holdings (LH) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Since a changing earnings ...

Core Viewpoint - The establishment of the intelligent laboratory at Zoucheng People's Hospital enhances access to high-precision medical testing services for local residents, improving healthcare quality and patient experience [3][5]. Group 1: Laboratory Establishment - The intelligent laboratory was inaugurated on September 29, with participation from local health officials and representatives from Mike Bio (300463) and Tongchuang Zhijian [1]. - The laboratory aims to break geographical and resource limitations, providing quality testing resources to grassroots medical institutions [3]. Group 2: Operational Enhancements - The hospital plans to strengthen laboratory management and operations, optimize workflows, and enhance personnel training to ensure quality control and safety management [5]. - The intelligent laboratory is seen as a key initiative to improve the hospital's core diagnostic capabilities and to provide personalized medical services [5]. Group 3: Advanced Equipment and Efficiency - The laboratory is equipped with advanced technology, including six blood collection windows and sorting machines capable of processing 3,000 samples per hour [8]. - The facility achieves a complete cycle of "intelligent testing - intelligent management - intelligent operation," with 80% of tasks automated, significantly improving report timeliness and resource optimization [8].

目前，检验结果智慧解读系统已在规范化建成的146家各级医疗机构实验室实现全覆盖，不仅显著提升了解读准确 率，更帮助基层实现了"检验不出社区、报告即时可读"。一位来自蓝田县的患者感慨道："以前为了一张报告往返 奔波，如今在家门口抽血，手机上立刻就能看明白，心里特别踏实。" 西安医检始终秉持"以技术赋能医疗，以数据守护健康"的建设理念。未来，西安医检将进一步拓展AI在疾病预 测、无人机送样及智慧医疗城市大脑融合等领域的应用，尤其在应急场景下，无人机快速送检较传统运输可节省 近三分之二时间，可极大缩短危急患者的等待窗口；助力构建从"诊断"到"预防"、从"单点服务"到"全域协同"的 智慧医疗新生态，让科技真正服务于民、惠及于民。 西安区域医学检验中心 曾经，一份检验报告满是难以读懂的数据与符号，如今只需扫码，AI 即时为您解读。检验结果智慧解读系统深度 融合了4000余个基于医学知识的解读模板，覆盖常见检验项目，并结合200余个经真实数据训练的AI分析模型， 实现对复杂指标的精准判断，不仅能清晰解释每一项指标，还能智能分析多份报告、提示异常关联指标，甚至预 测健康风险。自检验结果智慧解读系统上线以来，已累计完成报告解 ...

Group 1 - The 15th National Games and the 12th National Paralympic Games will be held in the Guangdong-Hong Kong-Macao Greater Bay Area, serving as a significant platform to showcase urban development, technological innovation, and regional cooperation [1][3] - The event is expected to enhance the overall image of the Greater Bay Area and deepen regional integration, with a focus on promoting public health management from "having" to "optimizing" [1] - The demand for event operations, health monitoring, and scientific fitness will drive breakthroughs and commercialization in AI medical big data, wearable devices, and smart healthcare [1] Group 2 - The integration of "sports + healthcare" is anticipated to break industry boundaries, attracting high-end resources to the Greater Bay Area and creating a "platform for events, stage for industries" effect [1] - The 15th National Games is viewed as an important opportunity to promote high-quality development in sports and public fitness [3] - A special column titled "15th Games 365 Days 365 People" will be launched to highlight stories and expectations surrounding the event, aiming to increase public awareness and engagement [3]

2023年、2024年，兰卫医学的营业收入分别为16.74亿元、17.42亿元；归属于上市公司股东的净利 润分别为-1.42亿元、-1.09亿元；归属于上市公司股东的扣除非经常性损益的净利润分别为-1.52亿 元、-1.09亿元。 兰卫医学上市发行费用总额为6139.68万元，其中保荐机构国金证券股份有限公司获得承销及保荐 费用4187.00万元。 | | 2024 年 | 2023 年 | 本年比上年增减 | 2022年 | | --- | --- | --- | --- | --- | | 营业收入(元) | 1,742,181,004.45 | 1,674,368,547.18 | 4.05% | 4,199,305,065.95 | | 归属于上市公司股东的净利润(元) | -109.436,220.80 | -141,591,451.29 | 22.71% | 617,322,755.95 | | 归属于上市公司股东的扣除非经常性 损益的净利润(元) | -109,080,713.70 | -151,870,353.46 | 28.18% | 646,127,081.09 | | 经营活动产生的现金 ...

9月22日，金域医学跌1.34%，截至发稿，报30.28元/股，成交1.49亿元，换手率1.07%，总市值140.27亿 元。金域医学股价已经连续6天下跌，区间累计跌幅7.11%。 资料显示，广州金域医学检验集团股份有限公司位于广东省广州市国际生物岛螺旋三路10号，成立日期 2006年5月26日，上市日期2017年9月8日，公司主营业务涉及为全国超过23,000家各类医疗机构提供包 括理化质谱检验、基因组检验、病理诊断、生化发光检验、免疫学检验、其他综合检验等六大类合计近 80类检验技术,近3,200项检验项目的外包及科研技术服务。主营业务收入构成为：医学诊断服务 91.20%，销售诊断6.45%，其他1.47%，冷链物流服务0.62%，健康体检业务0.27%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 责任编辑：小浪快报 数据显示，华宝基金旗下1只基金位居金域医学十大流通股东。华宝中证医疗ETF（512170）二季度减 持8.4万股，持有股数913.01万股，占流 ...

Core Viewpoint - The company will hold an online performance briefing on September 19, 2025, to discuss its half-year results and address investor questions [2][3][4]. Group 1: Meeting Details - The performance briefing is scheduled for September 19, 2025, from 15:30 to 17:00 [4]. - The meeting will take place on the "Panorama Roadshow" website [4]. - The format of the meeting will be an interactive text-based online session [3][5]. Group 2: Participation Information - Investors can participate in the interactive session on the "Panorama Roadshow" website during the specified time [5]. - Questions can be submitted via email to the company's securities affairs department by September 18, 2025, at 12:00 [5][6]. - The company will provide unified responses to commonly asked questions during the performance briefing [2][5]. Group 3: Contact Information - The contact department for inquiries is the Securities Affairs Department [6]. - The contact phone number is 020-29196326 [6]. - The email for question submissions is sid@kingmed.com.cn [7].

人民财讯9月11日电，康圣环球(09960.HK)消息，公司旗下武汉希诺医学检验实验室通过CAP(美国病理 学家协会)认证。 ...

Group 1 - Chengdu Meinian Medical Laboratory Co., Ltd. has been established with a registered capital of 10 million yuan [1] - The business scope includes inspection and testing services, operation of Class III medical devices, development of human genetic diagnosis and treatment technology, and information system integration services [1] - The company is wholly owned by Meinian Health (002044) through indirect shareholding [1]

Core Points - The company is holding its second extraordinary general meeting of shareholders in 2025 on September 9, 2025, at 14:30 [2][3] - The agenda includes four proposals, one of which is to cancel the supervisory board and amend the company's articles of association [7][8] - The meeting will utilize a combination of on-site and online voting methods for shareholders to exercise their voting rights [4][5] Proposal Summaries - **Proposal 1**: The company proposes to cancel the supervisory board and amend the articles of association and related rules to enhance corporate governance [7][8] - **Proposal 2**: The company aims to revise the related party transaction management system to improve governance and operational standards [9][10] - **Proposal 3**: The company intends to amend the external investment management system to align with current regulations and enhance operational efficiency [10][12] - **Proposal 4**: The company seeks to revise the external guarantee management system to ensure compliance with legal and regulatory requirements [12][13] Meeting Procedures - The meeting will be presided over by the chairman, and a secretary will be responsible for the meeting procedures [3][4] - Shareholders wishing to speak must register in advance, and the number of speakers may be limited to ten [6][7] - Voting will be conducted through a written ballot for on-site attendees and an online platform for remote participants [5][6]